Genotype-Based Molecular Mechanisms in Alport Syndrome
Journal of the American Society of Nephrology · 2025-06 · 36 (6) · 1176-1183
DOI: 10.1681/asn.0000000647 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 03.02.2025. Verfasst von Emine Bilge Caparali und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Southwestern, Dallas, Texas. Hauptthemen laut MEDLINE: Nephritis, Hereditary, Collagen Type IV. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Alport Syndrome Foundation.
Abstract (Originalsprache)
Alport syndrome is an inherited disorder characterized by kidney disease, sensorineural hearing loss, and ocular abnormalities. Alport syndrome is caused by pathogenic variants in COL4A3 , COL4A4 , or COL4A5 , which encode the α 3, α 4, and α 5 chains of type 4 collagen that forms a heterotrimer expressed in the glomerular basement membrane. Knowledge of its genetic basis has informed the development of different models in dogs, mice, and rats that reflect its autosomal and X-linked inheritance patterns as well as different mutation types, including protein-truncating and missense variants. A key difference between these two types is the synthesis of α 3 α 4 α 5(IV), which is not made in autosomal Alport syndrome (two pathogenic variants in trans or biallelic) or male patients with X-linked Alport syndrome due to protein-truncating variants. By contrast, α 3 α 4 α 5(IV) is synthesized in Alport syndrome because of missense variants. For missense variants, in vitro studies suggest that these cause impaired type 4 collagen trafficking and endoplasmic reticulum stress. For protein-truncating variants, knockout models suggest that persistence of an immature α 1 α 1 α 2(IV) network is associated with biomechanical strain, which activates endothelin-A receptors leading to mesangial filopodia formation. Moreover, studies suggest that activation of collagen receptors, integrins and discoidin domain receptor 1, play a role in disease propagation. In this review, we provide an overview of how these genotype–phenotype mechanisms are key for a precision medicine–based approach in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Texas Southwestern, Dallas, Texas.
- Toronto General Hospital Research Institute, Toronto, Ontario, Canada.
- Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
- Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Vanessa De Gregorio, Moumita Barua
Förderung
- Alport Syndrome Foundation
Zitieren
APA
Caparali, E. B., De Gregorio, V., & Barua, M. (2025). Genotype-Based Molecular Mechanisms in Alport Syndrome. Journal of the American Society of Nephrology, 36(6), 1176-1183. https://doi.org/10.1681/asn.0000000647
Vancouver
Caparali EB, De Gregorio V, Barua M. Genotype-Based Molecular Mechanisms in Alport Syndrome. Journal of the American Society of Nephrology. 2025;36(6):1176-1183. doi:10.1681/asn.0000000647
BibTeX
@article{Caparali2025,
author = {Caparali, Emine Bilge and De Gregorio, Vanessa and Barua, Moumita},
title = {Genotype-Based Molecular Mechanisms in Alport Syndrome},
journal = {Journal of the American Society of Nephrology},
year = {2025},
volume = {36},
number = {6},
pages = {1176--1183},
doi = {10.1681/asn.0000000647}
}
EUVIMED